Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$241,071
+$36,116 QoQ
Shares Held
958
+6.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#3,810
of 4,153 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Old North State Wealth Management, LLC holds $15,824,159 across 7 Drug Manufacturers - General names. ABBV ranks #7 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BIIB |
Biogen Inc.
|
24,720 | $5,341,003 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
24,892 | $3,144,855 | |
| 3 | PFE |
Pfizer Inc
|
124,354 | $2,994,444 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,648 | $2,267,768 | |
| 5 | JNJ |
Johnson & Johnson
|
4,447 | $1,129,404 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,246 | $705,614 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
958 | $241,071 |
All Filings in ABBV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $241,071 | 958 | Shares | Sole | 2026-07-17 | |
| 2025-12-31 | $204,955 | 897 | Shares | Sole | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||